{"count": 30, "results": [{"_id": "33845931", "pmid": 33845931, "title": "Racial and ethnic differences in response to treatment for Marfan syndrome.", "journal": "Cardiol Young", "authors": ["Ayers R", "Kelleman M", "Iannucci G", "McCracken C", "Oster ME"], "date": "2021-12-01T00:00:00Z", "doi": "10.1017/S104795112100130X", "meta_date_publication": "2021 Dec", "meta_volume": "31", "meta_issue": "12", "meta_pages": "1991-1998", "score": 50278.273, "text_hl": "The 2014 Pediatric Heart Network randomised trial of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan syndrome@@@ paediatric and young adult @SPECIES_9606 @@@patients@@@ showed no treatment differences in the rate of aortic root growth over 3 years; however, they did not examine racial/ethnic differences, and recent data suggest that angiotensin receptor blockers may have different pharmacologic effects in different racial/ethnic populations. ", "citations": {"NLM": "Ayers R, Kelleman M, Iannucci G, McCracken C, Oster ME. Racial and ethnic differences in response to treatment for Marfan syndrome. Cardiol Young. 2021 Dec;31(12):1991-1998. PMID: 33845931", "BibTeX": "@article{33845931, title={Racial and ethnic differences in response to treatment for Marfan syndrome.}, author={Ayers R and Kelleman M and Iannucci G and McCracken C and Oster ME}, journal={Cardiol Young}, volume={31}, number={12}, pages={1991-1998}}"}}, {"_id": "32586526", "pmid": 32586526, "title": "Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.", "journal": "J Pediatr", "authors": ["Van Driest SL", "Sleeper LA", "Gelb BD", "Morris SA", "Dietz HC", "Forbus GA", "Goldmuntz E", "Hoskoppal A", "James J", "Lee TM", "Levine JC", "Li JS", "Loeys BL", "Markham LW", "Meester JAN", "Mital S", "Mosley JD", "Olson AK", "Renard M", "Shaffer CM", "Sharkey A", "Young L", "Lacro RV", "Roden DM"], "date": "2020-07-01T00:00:00Z", "doi": "10.1016/j.jpeds.2020.03.064", "meta_date_publication": "2020 Jul", "meta_volume": "222", "meta_issue": "", "meta_pages": "213-220.e5", "score": 50269.906, "text_hl": "Variants in @GENE_ADRB1 @GENE_153 @@@ADRB1@@@ and @GENE_CYP2C9 @GENE_1559 @@@CYP2C9@@@: Association with Response to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ and @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan Syndrome@@@.", "citations": {"NLM": "Van Driest SL, Sleeper LA, Gelb BD, Morris SA, Dietz HC, Forbus GA, Goldmuntz E, Hoskoppal A, James J, Lee TM, Levine JC, Li JS, Loeys BL, Markham LW, Meester JAN, Mital S, Mosley JD, Olson AK, Renard M, Shaffer CM, Sharkey A, Young L, Lacro RV, Roden DM. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome. J Pediatr. 2020 Jul;222():213-220.e5. PMID: 32586526", "BibTeX": "@article{32586526, title={Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.}, author={Van Driest SL and Sleeper LA and Gelb BD and Morris SA and Dietz HC and Forbus GA and Goldmuntz E and Hoskoppal A and James J and Lee TM and Levine JC and Li JS and Loeys BL and Markham LW and Meester JAN and Mital S and Mosley JD and Olson AK and Renard M and Shaffer CM and Sharkey A and Young L and Lacro RV and Roden DM}, journal={J Pediatr}, volume={222}, pages={213-220.e5}}"}}, {"_id": "35902413", "pmid": 35902413, "title": "Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices.", "journal": "Pediatr Cardiol", "authors": ["Robertson DM", "Truong DT", "Cox DA", "Carmichael HL", "Ou Z", "Minich LL", "Williams RV", "Selamet Tierney ES"], "date": "2022-07-28T00:00:00Z", "doi": "10.1007/s00246-022-02976-z", "meta_date_publication": "2022 Jul 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.71, "text_hl": "Pediatric Heart Network Trial of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ vs. @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in Children and Young Adults with @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan Syndrome@@@: Impact on Prescription Practices.", "citations": {"NLM": "Robertson DM, Truong DT, Cox DA, Carmichael HL, Ou Z, Minich LL, Williams RV, Selamet Tierney ES. Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices. Pediatr Cardiol. 2022 Jul 28;():. PMID: 35902413", "BibTeX": "@article{35902413, title={Pediatric Heart Network Trial of Losartan vs. Atenolol in Children and Young Adults with Marfan Syndrome: Impact on Prescription Practices.}, author={Robertson DM and Truong DT and Cox DA and Carmichael HL and Ou Z and Minich LL and Williams RV and Selamet Tierney ES}, journal={Pediatr Cardiol}}"}}, {"_id": "32820647", "pmid": 32820647, "title": "Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience.", "journal": "Clin Trials", "authors": ["Hamstra MS", "Pemberton VL", "Dagincourt N", "Hollenbeck-Pringle D", "Trachtenberg FL", "Cnota JF", "Atz AM", "Cappella E", "De Nobele S", "Grima J", "King M", "Korsin R", "Lambert LM", "MacNeal MK", "Markham LW", "MacCarrick G", "Sylvester DM", "Walter P", "Xu M", "Lacro RV", "Pediatric Heart Network Investigators"], "date": "2020-12-01T00:00:00Z", "doi": "10.1177/1740774520945988", "meta_date_publication": "2020 Dec", "meta_volume": "17", "meta_issue": "6", "meta_pages": "684-695", "score": 50256.582, "text_hl": "BACKGROUND/AIMS: The Pediatric Heart Network @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan@@@ Trial was a randomized trial comparing @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ on @DISEASE_Aortic_Root_Aneurysm @DISEASE_MESH:D000094628 @@@aortic root dilation@@@ in 608 children and young adults with @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan syndrome@@@. ", "citations": {"NLM": "Hamstra MS, Pemberton VL, Dagincourt N, Hollenbeck-Pringle D, Trachtenberg FL, Cnota JF, Atz AM, Cappella E, De Nobele S, Grima J, King M, Korsin R, Lambert LM, MacNeal MK, Markham LW, MacCarrick G, Sylvester DM, Walter P, Xu M, Lacro RV, Pediatric Heart Network Investigators. Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience. Clin Trials. 2020 Dec;17(6):684-695. PMID: 32820647", "BibTeX": "@article{32820647, title={Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience.}, author={Hamstra MS and Pemberton VL and Dagincourt N and Hollenbeck-Pringle D and Trachtenberg FL and Cnota JF and Atz AM and Cappella E and De Nobele S and Grima J and King M and Korsin R and Lambert LM and MacNeal MK and Markham LW and MacCarrick G and Sylvester DM and Walter P and Xu M and Lacro RV and Pediatric Heart Network Investigators}, journal={Clin Trials}, volume={17}, number={6}, pages={684-695}}"}}, {"_id": "25738682", "pmid": 25738682, "title": "Atenolol versus Losartan in Marfan's Syndrome.", "journal": "N Engl J Med", "authors": ["Treasure T", "Pepper J", "Mohiaddin R"], "date": "2015-03-05T00:00:00Z", "doi": "10.1056/NEJMc1500128", "meta_date_publication": "2015 Mar 5", "meta_volume": "372", "meta_issue": "10", "meta_pages": "978-9", "score": 50090.45, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan's Syndrome@@@.", "citations": {"NLM": "Treasure T, Pepper J, Mohiaddin R. Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med. 2015 Mar 5;372(10):978-9. PMID: 25738682", "BibTeX": "@article{25738682, title={Atenolol versus Losartan in Marfan's Syndrome.}, author={Treasure T and Pepper J and Mohiaddin R}, journal={N Engl J Med}, volume={372}, number={10}, pages={978-9}}"}}, {"_id": "7608315", "pmid": 7608315, "title": "Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome.", "journal": "J Clin Pharmacol", "authors": ["Phelps SJ", "Alpert BS", "Ward JL", "Pieper JA", "Lima JJ"], "date": "1995-03-01T00:00:00Z", "doi": "10.1002/j.1552-4604.1995.tb04057.x", "meta_date_publication": "1995 Mar", "meta_volume": "35", "meta_issue": "3", "meta_pages": "268-74", "score": 50089.76, "text_hl": "Absorption pharmacokinetics of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with the @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan syndrome@@@.", "citations": {"NLM": "Phelps SJ, Alpert BS, Ward JL, Pieper JA, Lima JJ. Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome. J Clin Pharmacol. 1995 Mar;35(3):268-74. PMID: 7608315", "BibTeX": "@article{7608315, title={Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome.}, author={Phelps SJ and Alpert BS and Ward JL and Pieper JA and Lima JJ}, journal={J Clin Pharmacol}, volume={35}, number={3}, pages={268-74}}"}}, {"_id": "25738680", "pmid": 25738680, "title": "Atenolol versus Losartan in Marfan's Syndrome.", "journal": "N Engl J Med", "authors": ["Lacro RV", "Dietz HC", "Mahony L"], "date": "2015-03-05T00:00:00Z", "doi": "10.1056/NEJMc1500128", "meta_date_publication": "2015 Mar 5", "meta_volume": "372", "meta_issue": "10", "meta_pages": "980-1", "score": 50089.55, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan's Syndrome@@@.", "citations": {"NLM": "Lacro RV, Dietz HC, Mahony L. Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med. 2015 Mar 5;372(10):980-1. PMID: 25738680", "BibTeX": "@article{25738680, title={Atenolol versus Losartan in Marfan's Syndrome.}, author={Lacro RV and Dietz HC and Mahony L}, journal={N Engl J Med}, volume={372}, number={10}, pages={980-1}}"}}, {"_id": "25738681", "pmid": 25738681, "title": "Atenolol versus Losartan in Marfan's Syndrome.", "journal": "N Engl J Med", "authors": ["Ziganshin BA", "Mukherjee SK", "Elefteriades JA"], "date": "2015-03-05T00:00:00Z", "doi": "10.1056/NEJMc1500128", "meta_date_publication": "2015 Mar 5", "meta_volume": "372", "meta_issue": "10", "meta_pages": "977-8", "score": 50089.55, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan's Syndrome@@@.", "citations": {"NLM": "Ziganshin BA, Mukherjee SK, Elefteriades JA. Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med. 2015 Mar 5;372(10):977-8. PMID: 25738681", "BibTeX": "@article{25738681, title={Atenolol versus Losartan in Marfan's Syndrome.}, author={Ziganshin BA and Mukherjee SK and Elefteriades JA}, journal={N Engl J Med}, volume={372}, number={10}, pages={977-8}}"}}, {"_id": "25738683", "pmid": 25738683, "title": "Atenolol versus Losartan in Marfan's Syndrome.", "journal": "N Engl J Med", "authors": ["Mallat Z", "Tedgui A"], "date": "2015-03-05T00:00:00Z", "doi": "10.1056/NEJMc1500128", "meta_date_publication": "2015 Mar 5", "meta_volume": "372", "meta_issue": "10", "meta_pages": "980", "score": 50089.55, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ in @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan's Syndrome@@@.", "citations": {"NLM": "Mallat Z, Tedgui A. Atenolol versus Losartan in Marfan's Syndrome. N Engl J Med. 2015 Mar 5;372(10):980. PMID: 25738683", "BibTeX": "@article{25738683, title={Atenolol versus Losartan in Marfan's Syndrome.}, author={Mallat Z and Tedgui A}, journal={N Engl J Med}, volume={372}, number={10}, pages={980}}"}}, {"_id": "25405392", "pmid": 25405392, "title": "Atenolol versus losartan in children and young adults with Marfan's syndrome.", "journal": "N Engl J Med", "authors": ["Lacro RV", "Dietz HC", "Sleeper LA", "Yetman AT", "Bradley TJ", "Colan SD", "Pearson GD", "Selamet Tierney ES", "Levine JC", "Atz AM", "Benson DW", "Braverman AC", "Chen S", "De Backer J", "Gelb BD", "Grossfeld PD", "Klein GL", "Lai WW", "Liou A", "Loeys BL", "Markham LW", "Olson AK", "Paridon SM", "Pemberton VL", "Pierpont ME", "Pyeritz RE", "Radojewski E", "Roman MJ", "Sharkey AM", "Stylianou MP", "Wechsler SB", "Young LT", "Mahony L", "Pediatric Heart Network Investigators"], "date": "2014-11-27T00:00:00Z", "doi": "10.1056/NEJMoa1404731", "meta_date_publication": "2014 Nov 27", "meta_volume": "371", "meta_issue": "22", "meta_pages": "2061-71", "score": 50081.836, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ in children and young adults with @<m>DISEASE_Marfan_Syndrome</m> @DISEASE_MESH:D008382 @@@Marfan's syndrome@@@.", "citations": {"NLM": "Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, Pearson GD, Selamet Tierney ES, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Wechsler SB, Young LT, Mahony L, Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27;371(22):2061-71. PMID: 25405392", "BibTeX": "@article{25405392, title={Atenolol versus losartan in children and young adults with Marfan's syndrome.}, author={Lacro RV and Dietz HC and Sleeper LA and Yetman AT and Bradley TJ and Colan SD and Pearson GD and Selamet Tierney ES and Levine JC and Atz AM and Benson DW and Braverman AC and Chen S and De Backer J and Gelb BD and Grossfeld PD and Klein GL and Lai WW and Liou A and Loeys BL and Markham LW and Olson AK and Paridon SM and Pemberton VL and Pierpont ME and Pyeritz RE and Radojewski E and Roman MJ and Sharkey AM and Stylianou MP and Wechsler SB and Young LT and Mahony L and Pediatric Heart Network Investigators}, journal={N Engl J Med}, volume={371}, number={22}, pages={2061-71}}"}}]}